Nebenwirkungen · Actos
Actos 15 mg tablets Actos 30 mg tablets Actos 45 mg tablets · Abschnitt 4.8 · PDF-Seite 8
HOS-091041 · Präparat HOS-084177
Mono- with with with with insulin therapy metformin sulpho- metformin nylurea and sulpho- nylurea Neoplasms benign, malignant and unspecified (including cysts and polyps) bladder cancer uncommon uncommon uncommon uncommon uncommon Blood and lymphatic system disorders anaemia common Immune System Disorders hypersensitivity and not known not known not known not known not known allergic reactions1 Metabolism and nutrition disorders hypo-glycaemia uncommon very common common appetite increased uncommon Nervous system disorders hypo-aesthesia common common common common common headache common uncommon dizziness common insomnia uncommon uncommon uncommon uncommon uncommon Eye disorders visual disturbance2 common common uncommon macular oedema not known not known not known not known not known Ear and labyrinth disorders vertigo uncommon Cardiac disorders heart failure3 common Respiratory, thoracic and mediastinal disorders dyspnoea common Gastrointestinal disorders flatulence uncommon common Skin and subcutaneous tissue disorders sweating uncommon
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2023-08-28T15:56:00Z · SHA-256 9db485a8edb528eab1b3fb65eee070f4e61e0143333341420cf15c5240029983 · Passage 51bf8129c040f367b6aa0619add8ac8737014773364d0591276dab004146677a · Zeichen 1782–3689 im Abschnitt